Anti-Proliferative and Anti-Migratory Activity of Licorice Extract and Glycyrrhetinic Acid on Papillary Thyroid Cancer Cell Cultures.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
08 Oct 2024
Historique:
received: 10 09 2024
revised: 03 10 2024
accepted: 05 10 2024
medline: 16 10 2024
pubmed: 16 10 2024
entrez: 16 10 2024
Statut: epublish

Résumé

Papillary thyroid cancer (PTC) is the 8th most common cancer among women overall. Licorice contains over 300 active compounds, many of them with anti-cancer properties. Glycyrrhetinic acid (GA) is a major component of licorice. The aim of this study was to investigate the potential anti-proliferative effects of licorice and GA on PTC cell cultures. Licorice extract (LE) was produced from the root and tested on BCPAP and K1 cell lines, as well as GA and aldosterone. We used the MTT test to investigate the anti-proliferative activity, the wound healing test for the migratory activity, and finally, we analyzed cell cycle distribution, apoptosis, and oxidative stress after LE, GA, or aldosterone incubation. Both LE and GA reduced cell viability at 48 h and cell migration at 24 h in both PTC cultures. Aldosterone reduced cell migration only in K1 cells. LE and GA induced cell cycle arrest in the G0/G1 phase in the BCPAP cell line, while LE and aldosterone induced it in the K1 culture. GA but not LE increased the apoptosis rate in both cell lines, whereas LE but not GA increased oxidative stress in both cultures. This study presents the first evidence of the in vitro anti-proliferative and anti-migratory activity of LE and GA on PTC.

Identifiants

pubmed: 39409128
pii: ijms251910800
doi: 10.3390/ijms251910800
pii:
doi:

Substances chimiques

Glycyrrhetinic Acid P540XA09DR
Plant Extracts 0
Glycyrrhiza glabra extract 61ZBX54883

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Jacopo Manso (J)

Endocrinology Unit, Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.
Endocrinology and Metabolism Unit, University Hospital S. Maria della Misericordia of Udine, 33100 Udine, Italy.

Simona Censi (S)

Endocrinology Unit, Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Maria Chiara Pedron (MC)

Endocrinology Unit, Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Loris Bertazza (L)

Endocrinology Unit, Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Alberto Mondin (A)

Endocrinology Unit, Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Edoardo Ruggeri (E)

Endocrinology Unit, Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Susi Barollo (S)

Endocrinology Unit, Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Chiara Sabbadin (C)

Endocrinology Unit, Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Isabella Merante Boschin (I)

Department of Surgical, Oncological, and Gastroenterological Sciences, University of Padova, 35128 Padova, Italy.

Decio Armanini (D)

Endocrinology Unit, Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Caterina Mian (C)

Endocrinology Unit, Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH